As early stage adenocarcinomas already express moderate to high levels of KRT23 in vivo[14], we wanted to know whether depletion of KRT23 may affect the molecular and cellular functions of colon cancer cells. The gene discussed is KRT23; the disease is malignant colon neoplasm.